Predicted Trait | |
Reported Trait | Testicular cancer |
Mapped Trait(s) | testicular carcinoma (EFO_0005088) |
Additional Trait Information | https://biobankengine.stanford.edu/RIVAS_HG19/snpnet/cancer1045 |
Score Construction | |
PGS Name | GBE_cancer1045 |
Development Method | |
Name | snpnet |
Parameters | NR |
Variants | |
Original Genome Build | GRCh37 |
Number of Variants | 280 |
Effect Weight Type | NR |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000244 |
Citation (link to publication) | Tanigawa Y et al. PLoS Genet (2022) |
Ancestry Distribution | |
Score Development/Training | European: 100% 269,704 individuals (100%) |
PGS Evaluation | European: 66.7% South Asian: 33.3% 3 Sample Sets |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) | Phenotype Definitions & Methods | Age of Study Participants | Participant Follow-up Time | Additional Ancestry Description | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
— | [
|
European | UKB | — | — | — | white British ancestry | — |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM008542 | PSS007643| European Ancestry| 24,905 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Testicular cancer | — | AUROC: 0.89735 [0.86792, 0.92679] | R²: 0.1704 Incremental AUROC (full-covars): 0.01226 PGS R2 (no covariates): 0.01529 PGS AUROC (no covariates): 0.62484 [0.5376, 0.71208] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008543 | PSS007644| South Asian Ancestry| 7,831 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Testicular cancer | — | AUROC: 0.9816 [0.96678, 0.99641] | R²: 0.29699 Incremental AUROC (full-covars): 0.00299 PGS R2 (no covariates): 0.00616 PGS AUROC (no covariates): 0.386 [0.0998, 0.67219] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008544 | PSS007645| European Ancestry| 67,425 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Testicular cancer | — | AUROC: 0.83915 [0.8185, 0.85981] | R²: 0.1291 Incremental AUROC (full-covars): 0.03126 PGS R2 (no covariates): 0.01573 PGS AUROC (no covariates): 0.62956 [0.58302, 0.67611] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS007644 | — | — | [
|
— | South Asian | — | UKB | — |
PSS007645 | — | — | [
|
— | European | white British ancestry | UKB | Testing cohort (heldout set) |
PSS007643 | — | — | [
|
— | European | non-white British ancestry | UKB | — |